Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for ...
1d
Young people from less-advantaged backgrounds are more likely to have an undiagnosed eating disorder
Eating disorders are often associated with teenage girls from socioeconomically advantaged families. However, a new study ...
Over the past six months, psychologist Tom Hildebrandt has seen an increase in patients with eating disorders who are taking popular weight loss drugs like Wegovy or Zepbound. Subscribe to read this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results